Newfound Hope with CAR-T Treatment – Mylène’s Heartwarming Story
Swiss girl Mylène was diagnosed with acute lymphoblastic leukemia (ALL). Read about Mylene’s road to recovery with CAR-T therapy at Sheba Medical Center.
Results page
59 search results for: Car-T Treatment
On-site Manufacture of CAR-T Cells Enables Faster Effective Treatments
Study explores the benefits of treating patients with CAR-T cell therapeutics manufactured on-site, as opposed to using commercially manufactured products.
After Previous Treatments Had Failed – CAR-T Cell Therapy Saved Pedro da Silva’s Life
In 2013, Pedro da Silva received intensive chemotherapy treatment for testicular cancer. In 2016, he was diagnosed with leukemia.
CAR-T Leukemia Treatment Was Recently Recommended for FDA Approval
Chest pain is one of the most obvious heart attack symptoms. However, chest pain can also be a sign of less serious medical problems. This is why rapid discernment of chest pain is so critical.
Relapsed Multiple Myeloma Treatment in Israel
Learn more about CAR T-cell therapy at Sheba Medical Center for relapsed multiple myeloma
Latest Treatment for B-cell Non-Hodgkin’s Lymphoma in Israel
B-cell Non-Hodgkin’s Lymphoma treatment in Israel employs progressive techniques to fight cancer. Learn about the advanced and affordable therapies available at Sheba Medical Center
CAR T-cell treatment costs in Israel
Learn why receiving CAR T-cell treatment in Israel is more than just affordable.
Leukemia Treatment in Israel – The Latest Procedures
Learn about the advanced and affordable treatment options available for leukemia in Israel, such as CAR T-cell therapy.
Innovative hemato-oncological treatments
New studies indicate the high efficacy of novel immunotherapies, now available at Sheba, for patients with relapsed or refractory hematological malignancies.
Who Can Benefit from Acute Lymphoblastic Leukemia CAR-T Therapy in Israel?
Learn more about breakthrough CAR T-cell therapy at Sheba Medical Center, to treat ALL, including precursor B lymphoblastic leukemia.
